{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"8.210","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"827,000,000","primaryexch":"HKEX","ric":"2877.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":1.1121,"inline_upper_strike_price":"","sedol":"B045C04","am":"15.64","iv":"","ew_strike":"","as":"8.170","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"8.150","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-26 10:38:37.0","lo52":"6.960","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Li Zhenjiang","underlying_ric":"2877.HK","hi52":"10.760","issuer_name":"China Shineway Pharmaceutical Group Ltd.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"6.20","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"8.080","mkt_cap":"6.74","f_aum_hkd":null,"ew_sub_per_to":"","ls":"8.150","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"+0.010","aum":"","issued_shares_class_B":null,"vo":"1.92","secondary_listing_flag":false,"listing_date":"2 Dec 2004","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"China Shineway Pharmaceutical Group Ltd.","nm_s":"SHINEWAY PHARM","sym":"2877","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.","op":"8.190","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Chinese Medicines","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Suite 3109<br/>31/F Central Plaza<br/>18 Harbour Road<br/>Wanchai, Hong Kong","pc":"+0.12","days_to_expiry":null,"underlying_code":null,"pe":"6.93","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"8.140","isin":"KYG2110P1000","moneyness":""}},"qid":"1758890358137"}
